SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Colas move to record highs is being linked to KFCs planned switch from Pepsi to Coke across its U.S. restaurants, which traders view as a distribution win amid KOs outperformance of Pepsi. The reaction is broadly bullish, though some traders caution that the rally has stretched the stocks valuation.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is drawing attention after a prolonged selloff in Chinese internet stocks, with traders split between bottom-fishing for an oversold bounce and expecting further weakness. Bulls point to depressed valuations and technical support, while bears cite Chinas weak demand, limited market inflows, and persistent policy and geopolitical risks.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is drawing attention amid volatile natural-gas futures trading around weather forecasts and EIA storage data. Traders are split on whether heat and tighter storage can offset a mild shoulder-season outlook, strong production, and returning pipeline and LNG flows; many also caution that BOILs leverage and futures-roll decay amplify the risk.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

A prolonged selloff in obesity-focused biotech has put GPCR under scrutiny, with traders debating whether the drop reflects sector weakness and skepticism about alenigliprons efficacy, tolerability and long Phase 3 timeline. Some investors view the companys cash and oral obesity pipeline as undervalued, while others cite intense competition and clinical risks; buyout talk remains speculative.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention over lawsuits alleging brake-master-cylinder failures and 6.2L V8 engine defects, though the cases remain unresolved and no class has been certified. Traders are also weighing declining Q3 U.S. sales and weak EV demand against bullish technical setups and positioning ahead of earnings.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnights mainnet launch and ecosystem announcements, including Google and Vodafone validator participation and planned financial-use cases, are driving attention to the privacy-focused Cardano network. Traders are split between optimism about adoption and concern that airdrop redemptions and token selling are weighing on NIGHT, while some question the networks decentralization and near-term traction.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

ICP is drawing attention for choppy, range-bound trading and repeated failed breakouts, with traders watching whether support holds as broader crypto weakness weighs on sentiment. The community is split between criticism of weak momentum and low volume, and long-term optimism about decentralized computing, AI infrastructure, and potential adoptionwhose ability to translate into meaningful demand remains contested.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINK is drawing attention amid volatile, choppy price action, with traders debating whether recent weakness is a buying opportunity or a failed breakout. Bullish holders point to Chainlinks institutional and tokenization integrations, while skeptics question whether network adoption translates into value for the LINK token and some blame selling pressure without evidence.

WorldFinancial

World Liberty Financials preliminary conditional OCC approval to establish a national trust bank for its USD1 stablecoin is driving attention, with bullish traders viewing future banking operations and token utility as potential catalysts. Others say the news has not translated into sustained token strength and raise concerns about the project and its selloff; predictions of a low-float squeeze remain speculative.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Attention centers on Alpha Taus completed enrollment in its expanded pancreatic-cancer IMPACT study and a pipeline of upcoming clinical milestones, including updates in glioblastoma and ReSTART; traders view the enrollment expansion as encouraging and are accumulating shares ahead of data. Sentiment is largely bullish, though some traders point to pullbacks and resistance near recent highs and note that clinical readouts remain uncertain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of...

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler...

Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation CURX

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) resulting...

What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours

Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis. read more...

Curanex Pharmaceuticals, Inc. engages in the pharmaceutical business. It focuses on developing and commercializing botanical treatments for inflammatory diseases. The company was founded by Ying Jing and Chang Liu in 1996 and is headquartered in Jericho, NY.

Curanex Pharmaceuticals Inc.

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

Curanex Pharmaceuticals Inc

$CURX Current float is sitting around 600K, with the stock trading near its 52-week low. 
 
The setup looks interesting for a big potential to go parabolic, definitely one worth keeping an eye on.

Feed

News

Sentiment

Fundamentals

Info

CURX Curanex Pharmaceuticals Inc

Fundamentals

Latest CURX News